March 30-Apr 1, 2011 - ICON plc

Friday | April 1st, 2011 | General SessionTechnology7:00 Stand up 2 Cancer Morning yogaBring your gear to work up a sweat during some morning stretches that will keepyou energized throughout the day! RPS will generously make a donation for allparticipants. Yoga will be held at the Sheraton Phoenix Downtown Hotel. Sign up inadvance at the RPS booth.8:00-8:45 Market insight Roundtable Discussions (see page 14 for details)8:00-9:00 Morning Coffee in the Partnerships Hall9:00 Chairpersons RecapJohn W. Hubbard, PhD, FCP,Senior Vice President, Headof Worldwide DevelopmentOperations Worldwide R&D,pFizER, inC.Harris Koffer, PharmDPresident and COORpS, inC.9:45 Leverage the value of your Technology – Explore How the patientwill be the Game Changer for Clinical Drug DevelopmentScience and medicine journalist and acclaimed author, Thomas Goetz, shares insightsfrom his new book “The Decision Tree” and how it applies to the pharmaceuticalmarketplace. This lively discussion identifi es trends on how consumers engage withtechnology in the healthcare space.• Explore how consumers interact with data, and how variables are broken downinto metrics, analyzed, and factored into health decisions• Learn how data-crunching tools and bioinformatics infl uence the knowledgeof how diseases work in the body and the discovery of new drug targets thatimpact the future of clinical drug development• Hear about the latest tools patients use to share their health experienceand manage disease• Identify specifi c trends and approaches that help patients selectively useinformation to elevate sound science in a relevant, personalized wayThomas Goetz, MPHExecutive Editor, WiRED MAGAzinEAuthor, The Decision Tree9:15 inspirational patient Advocate perspective with MLb LegendCurt SchillingCurt Schilling shares the story of his son’s Asperger’s syndrome and how it changedhis family’s journey. As an active patient advocate for amyotrophic lateral sclerosis(ALS) sufferers, Schilling’s organization, Curt’s Pitch for ALS, allows fans andorganizations to sponsor him and donate to the ALS Association for every strikeouthe throws. In 2007, Schilling released a charity wine called Schilling Schardonnaywith 100% of the proceeds supporting Curt’s Pitch for ALS. He also supports his wifeShonda’s personal charity, The Shade Foundation of America, an organization devotedto eradicating melanoma through the education of children and the community inthe prevention and detection of skin cancer and the promotion of skin safety. Comehear Schilling draw on his personal and professional experiences to teach leadershiplessons to help save lives.Curt Schilling, Former Major League Baseball Pitcher and 3 Time World SeriesChampion; Founder and Chairman, 38 Studios and Founder, Curt’s pitch for ALS10:30 Networking Break and photo opportunity with Curt Schillingin the Partnerships Hall11:00-12:30 S C O R E tracks and Market insight RoundtableDiscussions (see pages 14-15)12:30-1:30 Networking Luncheon in the Partnerships HallGreat introductions, good ability to drill down in tracks,and fun after hours sponsored activities.– Jane Brennan, Associate Contracts Manager, Corporate Purchasing,GENZYME CORP“”Innovation1:30 Strategy is innovation: Solving the Execution ChallengeWe live in an era of almost constant change. First, new technologies continueto emerge at an ever-more rapid pace. Second, globalization brings with it newmarkets, new customers, nontraditional competitors, and new challenges. Third, theInternet has created much greater transparency to any company’s strategy, actions,and performance. As a result of these forces, companies fi nd that their strategiesneed almost constant redefi nition – either because the old assumptions are nolonger valid, or because the previous strategy has been imitated and neutralizedby competitors, or because technological developments and globalization offerunanticipated opportunities. Rooted in these premises, the strategic challenges fororganizations become: How do we identify the market discontinuities that couldtransform our industry? How do we analyze the opportunities and risks as a result ofour understanding of market discontinuities? How can we create new growth platformswith a view to exploit the market discontinuities? What are our core competencies andhow can we leverage them in the growth platforms? How do we allocate resources tosupport growth? What kind of organizational DNA must we have in order to anticipateand respond to changes on a continual basis? How do you execute breakthroughstrategies? Develop a framework to answer the following questions:• Why do companies need to continuously innovate strategically?• How can fi rms identify market discontinuities that shape the future evolutionof the industry?• How can fi rms exploit accelerating global opportunities as a result of thediscontinuous shifts in the marketplace?• How can fi rms build the requisite organizational DNA to create the future whilemanaging the present?• How do you execute breakthrough strategies in the pharmaceutical industry?Vijay Govindarajan, Founding Director of the Center for Global Leadership at the TuckSchool of Business, DARTMOuTH COLLEGE, Co-author, The Other Side of Innovation:Solving the Execution Challenge“As we struggle with the pressure of doing more with less in ourmotivation to develop new therapies for patients in need, Partnershipsprovides a forum to hear leading sponsors and providers discussthe challenges, present creative solutions and permits interactivedialogue that I find unlike another meeting in our industry– Larry Blankstein, Senior Director, Clinical Research, GENZYME”2:15 industry Future – C-Suite Fireside ChatFor the past several years, an economic recession, mergers and acquisitions, patentcliffs, product pipeline rationalizations, and changes in the way pharmaceuticalcompanies invest in R&D have been impacting the healthcare industry. This sessionlooks at macroeconomic trends, strategies, and practices as well as analogies drawnfrom other R&D intensive industries to project where sponsor-CRO relationships areheaded. Discuss some of the recent factors driving change in the industry and explorenew business paradigms for partnering with clients to enhance value and expeditedrug development. Panelists explore the following issues:• What will Pharma look like in 5 years time and how will we get there?• How will comparative effectiveness research impact the industry with strategies forclinical trial designs and drug development?• What are the projected changes in discovery, preclinical, early clinical, and laterstage clinical outsourcing?• How do you improve the organizational effi ciency as a part of the newvalue equation?• How do you expect the CRO-Sponsor relationship to change in the next decade?Vijay Govindarajan, Founding Director of the Center for Global Leadership at the TuckSchool of Business, DARTMOuTH COLLEGE, Co-author, The Other Side of Innovation:Solving the Execution Challenge (Moderator)James T. Ogle, CEO, inC RESEARCHJeffrey P. McMullen, CEO, pHARMAnET3:00 partnerships Hall of Fame Awards CeremonyAn awards ceremony will honor and celebrate Partnership MVPs throughout thepast 20 years. Come celebrate the achievements of your colleagues! Winners forthe following categories will be announced: Technology and Innovation, LifetimeAchievement Award, Operational Excellence, Change Management, Most ValuableAttendee, and more.3:30 Main Conference Concludes3:30-5:00 post Conference intensivesThese 90 minute intensives take a deep dive into some specialized topicareas in the industry. See page 15 for a list of sessions offered. Please visitour website for updates.www.clinicaltrialpartnerships.com9